Acetylsalicylic Acid — Drug Intelligence | 81 EU Trials

Filter these 81 trials by condition, phase, country and more.

Open in Search →

81 Registered trials

36 Recruiting

26 Completed trials

68 Sponsors

26 Countries

Phase III

Phase II

Phase IV

Phase III: 34 Phase II/III: 3 Phase II: 10 Phase III/IV: 6 Phase IV: 28

Oversight events:

1 serious breach 4 temporary halts 2 unexpected events 2 corrective measures across 7 trials

View oversight register →

Indications tested

Acute coronary syndrome 6 Atrial fibrillation 5 Coronary artery disease 5 Chronic coronary syndrome 3 Colon cancer stage II 2 Ischaemic stroke 2 Pre-eclampsia 2 Colon cancer stage III 2 Aortic stenosis 2 Overweight 1 Peripheral artery surgery 1 Atrial flutter 1

Sponsors using this IMP

Fondazione IRCCS Istituto Nazionale Dei Tumori 3 St Antonius Hospital 3 Amsterdam UMC 2 Assistance Publique Hopitaux De Paris 2 Centre hospitalier universitaire de Liege 2 Fundacion Epic 2 Janssen - Cilag International 2 Medical University Of Graz 2 Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut Badawczy 2 Oslo University Hospital HF 2 Region Midtjylland 2 Rigshospitalet 2

All trials — page 4

81 total

Long-term aspirin therapy as a predictor of decreased susceptibility to SARSCoV-2 infection in aspirin-exacerbated respiratory disease Ended

2024-514602-31-00 Phase II/III 1 country Uniwersytet Jagiellonski Collegium Medicum
Patient reported efficacy of intranasal lysine-aspirin in controlling NSAID-exacerbated respiratory disease. Ended

2024-517437-40-00 Phase II 1 country UZ Leuven
ATILA Project: Aspirin Versus Tirofiban in Endovascular Treatment for Patients With Acute Ischemic Stroke Due to Tandem Lesion Ended

2023-508454-26-00 Phase IV 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
A prospective interventional randomized controlled trial to assess the effect of low dose acetylsalicylic acid as a preventive treatment of … Ended

2024-516816-72-00 Phase III 1 country Centre Hospitalier Universitaire De Liege
Evaluation of safety i efficacy de-escalation antiplatelet strategies in acute coronary syndrome. Ended

2024-518090-34-00 Phase III 1 country Nicolaus Copernicus University
Escalated single Platelet Inhibition for one month plus Direct oral anticoagulation in patients with Atrial fibrillation and acUte coRonary … Ended

2024-512727-36-00 Phase IV 2 countries Klinikum der Universitaet Muenchen AöR
PROgnostic value of precision medicine in patients with Myocardial Infarction and non-obStructive coronary artEries: the PROMISE study Ended

2024-518724-72-00 Phase IV 1 country Fondazione Policlinico Universitario Agostino Gemelli IRCCS
A study designed to evaluate a modified Anti-Platelet Therapy (drugs that preventblood platelets from clotting) after implantation of a Fire… Ended

2024-519854-35-00 Phase IV 3 countries SORIN CRM SAS (Microport CRM)
The Optimal Anticoagulation for Enhanced Risk Patients Post-Catheter Ablation for Atrial Fibrillation Trial Ended

2024-518736-37-00 Phase IV 2 countries University Of Ottawa Heart Institute

Showing 73–81 of 81 trials

← All drugs A–Z